Protective effects of specific platelet-activating factor receptor antagonists in experimental glomerulonephritis

J. Yoo, D. Schlondorff, Joel Neugarten

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The present study was undertaken to evaluate the hypothesis that enhanced production of platelet-activating factor (PAF) contributes to the renal hemodynamic alterations and impaired glomerular permselectivity that characterize the heterologous phase of nephrotoxic serum nephritis. Intravenous administration of nephrotoxic gamma globulin to normal rats led to a rapid decline in glomerular filtration rate within 60 min from 1.08 ± 0.08 to 0.45 ± 0.12 ml/min/100 g b.wt., P < .001, and in effective renal plasma flow rate from 2.56 ± 0.15 to 1.35 ± 0.21 ml/min/100 g b.wt., P < .02. Concomitantly, the fractional excretion of protein rose from 3.4 ± 0.6 x 10-5 to 11.6 ± 2.3 x 10-5, P < .03. Pretreatment with the specific PAF receptor antagonists WEB 2086 or WEB 2170 significantly ameliorated the impairment in glomerular filtration rate and in effective renal plasma flow rate induced by nephrotoxic globulin. Filtration rate declined by 0.63 ± 0.12 ml/min/100 g b.wt. 60 min after administration of nephrotoxic globulin, but fell only 0.30 ± 0.14 ml/min/100 g b.wt. in rats pretreated with WEB 2086, P < .05 and 0.34 ± 0.11 ml/min/100 g b.wt. in rats pretreated with WEB 2170, P < .01. The decline in effective renal plasma flow rate 60 min after administration of nephrotoxic globulin was 1.21 ± 0.30 ml/min/100 g b.wt., but only 0.86 ± 0.23 ml/min/100 g b.wt. in rats pretreated with WEB 2086, NS, and 0.52 ± 0.21 ml/min/100 g b.wt. in rats pretreated with WEB 2170, P < .003. The rise in fractional excretion of protein induced by nephrotoxic globulin was also ameliorated in animals pretrated with either PAF receptor antagonist. Administration of nephrotoxic globulin was not associated with altered glomerular size selectivity as assessed by the fractional clearance of neutral dextrans, suggesting that the observed defect in glomerular permselectivity was due to altered glomerular charge selectivity. In rats pretreated with a PAF receptor antagonist, the fractional excretion of protein failed to increase and fractional dextran clearances were unchanged, suggesting that PAF contributes to impaired glomerular charge selectivity in this model. Our data suggest that PAF is one of the mediators of the glomerular hemodynamic and permselective responses early in the heterologous phase of nephrotoxic serum nephritis.

Original languageEnglish (US)
Pages (from-to)841-844
Number of pages4
JournalJournal of Pharmacology and Experimental Therapeutics
Volume256
Issue number3
StatePublished - 1991

Fingerprint

WEB 2086
Glomerulonephritis
Globulins
Effective Renal Plasma Flow
Platelet Activating Factor
Nephritis
Dextrans
Glomerular Filtration Rate
Hemodynamics
Proteins
gamma-Globulins
Serum
Intravenous Administration
platelet activating factor receptor
Kidney
bepafant

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{36190e9b501e4cbab792ebcefdfba3d6,
title = "Protective effects of specific platelet-activating factor receptor antagonists in experimental glomerulonephritis",
abstract = "The present study was undertaken to evaluate the hypothesis that enhanced production of platelet-activating factor (PAF) contributes to the renal hemodynamic alterations and impaired glomerular permselectivity that characterize the heterologous phase of nephrotoxic serum nephritis. Intravenous administration of nephrotoxic gamma globulin to normal rats led to a rapid decline in glomerular filtration rate within 60 min from 1.08 ± 0.08 to 0.45 ± 0.12 ml/min/100 g b.wt., P < .001, and in effective renal plasma flow rate from 2.56 ± 0.15 to 1.35 ± 0.21 ml/min/100 g b.wt., P < .02. Concomitantly, the fractional excretion of protein rose from 3.4 ± 0.6 x 10-5 to 11.6 ± 2.3 x 10-5, P < .03. Pretreatment with the specific PAF receptor antagonists WEB 2086 or WEB 2170 significantly ameliorated the impairment in glomerular filtration rate and in effective renal plasma flow rate induced by nephrotoxic globulin. Filtration rate declined by 0.63 ± 0.12 ml/min/100 g b.wt. 60 min after administration of nephrotoxic globulin, but fell only 0.30 ± 0.14 ml/min/100 g b.wt. in rats pretreated with WEB 2086, P < .05 and 0.34 ± 0.11 ml/min/100 g b.wt. in rats pretreated with WEB 2170, P < .01. The decline in effective renal plasma flow rate 60 min after administration of nephrotoxic globulin was 1.21 ± 0.30 ml/min/100 g b.wt., but only 0.86 ± 0.23 ml/min/100 g b.wt. in rats pretreated with WEB 2086, NS, and 0.52 ± 0.21 ml/min/100 g b.wt. in rats pretreated with WEB 2170, P < .003. The rise in fractional excretion of protein induced by nephrotoxic globulin was also ameliorated in animals pretrated with either PAF receptor antagonist. Administration of nephrotoxic globulin was not associated with altered glomerular size selectivity as assessed by the fractional clearance of neutral dextrans, suggesting that the observed defect in glomerular permselectivity was due to altered glomerular charge selectivity. In rats pretreated with a PAF receptor antagonist, the fractional excretion of protein failed to increase and fractional dextran clearances were unchanged, suggesting that PAF contributes to impaired glomerular charge selectivity in this model. Our data suggest that PAF is one of the mediators of the glomerular hemodynamic and permselective responses early in the heterologous phase of nephrotoxic serum nephritis.",
author = "J. Yoo and D. Schlondorff and Joel Neugarten",
year = "1991",
language = "English (US)",
volume = "256",
pages = "841--844",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Protective effects of specific platelet-activating factor receptor antagonists in experimental glomerulonephritis

AU - Yoo, J.

AU - Schlondorff, D.

AU - Neugarten, Joel

PY - 1991

Y1 - 1991

N2 - The present study was undertaken to evaluate the hypothesis that enhanced production of platelet-activating factor (PAF) contributes to the renal hemodynamic alterations and impaired glomerular permselectivity that characterize the heterologous phase of nephrotoxic serum nephritis. Intravenous administration of nephrotoxic gamma globulin to normal rats led to a rapid decline in glomerular filtration rate within 60 min from 1.08 ± 0.08 to 0.45 ± 0.12 ml/min/100 g b.wt., P < .001, and in effective renal plasma flow rate from 2.56 ± 0.15 to 1.35 ± 0.21 ml/min/100 g b.wt., P < .02. Concomitantly, the fractional excretion of protein rose from 3.4 ± 0.6 x 10-5 to 11.6 ± 2.3 x 10-5, P < .03. Pretreatment with the specific PAF receptor antagonists WEB 2086 or WEB 2170 significantly ameliorated the impairment in glomerular filtration rate and in effective renal plasma flow rate induced by nephrotoxic globulin. Filtration rate declined by 0.63 ± 0.12 ml/min/100 g b.wt. 60 min after administration of nephrotoxic globulin, but fell only 0.30 ± 0.14 ml/min/100 g b.wt. in rats pretreated with WEB 2086, P < .05 and 0.34 ± 0.11 ml/min/100 g b.wt. in rats pretreated with WEB 2170, P < .01. The decline in effective renal plasma flow rate 60 min after administration of nephrotoxic globulin was 1.21 ± 0.30 ml/min/100 g b.wt., but only 0.86 ± 0.23 ml/min/100 g b.wt. in rats pretreated with WEB 2086, NS, and 0.52 ± 0.21 ml/min/100 g b.wt. in rats pretreated with WEB 2170, P < .003. The rise in fractional excretion of protein induced by nephrotoxic globulin was also ameliorated in animals pretrated with either PAF receptor antagonist. Administration of nephrotoxic globulin was not associated with altered glomerular size selectivity as assessed by the fractional clearance of neutral dextrans, suggesting that the observed defect in glomerular permselectivity was due to altered glomerular charge selectivity. In rats pretreated with a PAF receptor antagonist, the fractional excretion of protein failed to increase and fractional dextran clearances were unchanged, suggesting that PAF contributes to impaired glomerular charge selectivity in this model. Our data suggest that PAF is one of the mediators of the glomerular hemodynamic and permselective responses early in the heterologous phase of nephrotoxic serum nephritis.

AB - The present study was undertaken to evaluate the hypothesis that enhanced production of platelet-activating factor (PAF) contributes to the renal hemodynamic alterations and impaired glomerular permselectivity that characterize the heterologous phase of nephrotoxic serum nephritis. Intravenous administration of nephrotoxic gamma globulin to normal rats led to a rapid decline in glomerular filtration rate within 60 min from 1.08 ± 0.08 to 0.45 ± 0.12 ml/min/100 g b.wt., P < .001, and in effective renal plasma flow rate from 2.56 ± 0.15 to 1.35 ± 0.21 ml/min/100 g b.wt., P < .02. Concomitantly, the fractional excretion of protein rose from 3.4 ± 0.6 x 10-5 to 11.6 ± 2.3 x 10-5, P < .03. Pretreatment with the specific PAF receptor antagonists WEB 2086 or WEB 2170 significantly ameliorated the impairment in glomerular filtration rate and in effective renal plasma flow rate induced by nephrotoxic globulin. Filtration rate declined by 0.63 ± 0.12 ml/min/100 g b.wt. 60 min after administration of nephrotoxic globulin, but fell only 0.30 ± 0.14 ml/min/100 g b.wt. in rats pretreated with WEB 2086, P < .05 and 0.34 ± 0.11 ml/min/100 g b.wt. in rats pretreated with WEB 2170, P < .01. The decline in effective renal plasma flow rate 60 min after administration of nephrotoxic globulin was 1.21 ± 0.30 ml/min/100 g b.wt., but only 0.86 ± 0.23 ml/min/100 g b.wt. in rats pretreated with WEB 2086, NS, and 0.52 ± 0.21 ml/min/100 g b.wt. in rats pretreated with WEB 2170, P < .003. The rise in fractional excretion of protein induced by nephrotoxic globulin was also ameliorated in animals pretrated with either PAF receptor antagonist. Administration of nephrotoxic globulin was not associated with altered glomerular size selectivity as assessed by the fractional clearance of neutral dextrans, suggesting that the observed defect in glomerular permselectivity was due to altered glomerular charge selectivity. In rats pretreated with a PAF receptor antagonist, the fractional excretion of protein failed to increase and fractional dextran clearances were unchanged, suggesting that PAF contributes to impaired glomerular charge selectivity in this model. Our data suggest that PAF is one of the mediators of the glomerular hemodynamic and permselective responses early in the heterologous phase of nephrotoxic serum nephritis.

UR - http://www.scopus.com/inward/record.url?scp=0025758753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025758753&partnerID=8YFLogxK

M3 - Article

VL - 256

SP - 841

EP - 844

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -